Traws Pharma, Inc. (TRAW) Misses Q3 EPS by 856c
Tweet
Share
E-mailGet Alerts TRAW Hot Sheet
Join SI Premium – FREE
Traws Pharma, Inc. (NASDAQ: TRAW) reported Q3 EPS of ($8.81), $8.56 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $60 thousand versus the consensus estimate of $58 thousand.
For earnings history and earnings-related data on Traws Pharma, Inc. (TRAW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Former Fed Chair Alan Greenspan Dies Aged 100, NBC Reports
- Vicor Corporation (VICR) PT Raised to $400 at Needham
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
